HORIZON-HLTH-2022-TOOL-011-01-single-stage

December 23, 2021

Health: Destination 5: Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers

Clinical validation of qualified biomarkers (not limited to molecular biomarkers) that will enable the identification of appropriate patients to ensure an effective and efficient use of existing pharmaceuticals in the treatment of major diseases and conditions. The relevant biomarkers should allow providing the right medicinal product, at the right dose and the right time, according to the concept of personalized medicine, taking into account, among others, differences of sex, age, ethnicity and gender identity. This topic refers to medicines that are already on the market and not to the validation of biomarkers for the development of new medicinal products. A condition is that  preliminary studies or publications have demonstrated that the pharmaceuticals considered are efficient in less than 50% of the population treated. This topic excludes cancer and rare disease treatments.

Project budget: 10M (Total budget 60M); Deadline: 21 April 2022. More

Become a member

You are not a member yet? Subscribe here to join the OoC community.

Join us

Stay tuned

Become a member
WHAT IS THE ADVANTAGE OF JOINING THE OoC COMMUNITY ? registration

Academic

  • Keep up to date on the latest news and events
  • Share information
  • Find expertise/collaboration

 

Industrial

  • Keep informed about new scientific and technological developments
  • Find academic/private partners
  • Gain in visibility and awareness of your activity

Individual

  • Get a better understanding of OoC field (applications, challenges)
  • Be updated about OoC
  • Be part of the network

Sentence about data protection vocabulo circulo abdita lunari semper theologi etiam alii filiam duplici.

Academic

Keep up to date on the latest news and events

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Industrial

Keep informed about new scientific and technological developments

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Individual

Be updated about OoC / Get a better understanding of OoC

Personalized subscription fees (in progress):

  • Free Membership

  • Premium Membership







Sentence about data protection vocabulo circulo
abdita lunari semper theologi etiam alii filiam
duplici.

Reserved
ACCESS

Return
Join us !

Would you like to know more ?
Join us and share the latest advances in OoC Research, be informed about emerging OoC projects, about who are the European leading experts, the novel applications, partners and much more

(Note: free membership gives you access to the library)

OR

Connect to your personal space

Forgot your password?
OR